IKK β Antibody (YA7485)

(Synonyms: IKKB, IKBKB, Inhibitor of nuclear factor kappa-B kinase subunit beta, I-kappa-B-kinase beta, IKK-B, IKK-beta, IkBKB, I-kappa-B kinase 2, Nuclear factor NF-kappa-B inhibitor kinase beta, Serine/threonine protein kinase IKBKB, IKK-2, IKK2, NFKBIKB)

IKK β Antibody (YA7485) is a Rabbit-derived and non-conjugated IgG, Kappa monoclonal antibody, targeting to IKK β.

For research use only. We do not sell to patients.
  • Host:

    Rabbit

  • Isotype:

    IgG

  • Application:

    WB, ICC/IF, IP, ELISA

  • Reactivity :

    Human, Mouse, Rat

  • Formulation:

    Supplied in PBS (pH7.4) containing 50% glycerol, 0.05% Proclin 300, 0.05%BSA

  • Conjugation:
    Non-conjugated

Applications

Application
WB Info
WB: Western Blot
ICC/IF Info
ICC/IF: Immunocytochemistry/
Immunofluorescence
ELISA Info
ELISA: Enzyme Linked Immunosorbent Assay
IP Info
IP: Immunoprecipitation
Dilution Ratio 1:2000-1:10000 1:200-1:1000 1:5000-1:20000 1:50-1:200

Product Details

Description

IKK β Antibody (YA7485) is a Rabbit-derived and non-conjugated IgG, Kappa monoclonal antibody, targeting to IKK β.

  • Host Rabbit
  • Clonality Monoclonal,Recombinant
  • Species Reactivity
    Human, Mouse, Rat
  • Observed Molecular Weight
    Observed band size: 87 kDa Info
    Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
  • Calculated Molecular Weight Predicted band size: 87 kDa
Immunogen

The exact sequence is proprietary to MCE.

Sensitivity

Endogenous

Purification

Protein A affinity purified

Conjugation

Non-conjugated

Modification

Unmodified

Isotype

IgG

Product Properties

  • Appearance

    Solution

  • Formulation

    Supplied in PBS (pH7.4) containing 50% glycerol, 0.05% Proclin 300, 0.05%BSA

  • Storage & Stability

    Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

  • Shipping

    Shipping with blue ice.

Verification Images

  • Experimental Validation Results for IKK β Antibody (YA7485)
    Western blot analysis was performed on extracts from HL60 (lane 1, 20μg), HT22 (lane 2, 20μg), HCT116 (lane 3, 20μg), A594 (lane 4, 20μg), using IKK β Antibody (YA7485). Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST at 25°C for 1hour.The primary antibody (1:2000 dilution) and the loading control antibody (GAPDH, HY-P83944, 1:3000 dilution) were incubated in 5% non-fat milk in TBST for overnight. AF800-conjugated Goat Anti-Rabbit IgG H&L(HY-P810687, 1:1000 dilution) and AF680-conjugated Goat Anti-Mouse IgG H&L(HY-P89186 , 1:10000 dilution) was then applied for 1 hour at 37°C, protect from light.

Background

  • Function

    IKK-β (IKBKB) is a catalytic subunit of the IκB kinase (IKK) complex and functions as a central signal integration node that regulates canonical NF-κB signaling, inflammatory responses, cell survival, and immune activation[1]. Mechanistically, activated IKK-β phosphorylates inhibitory IκB proteins, promoting their ubiquitin-dependent degradation and releasing NF-κB transcription factors for nuclear translocation and target gene expression[2]. Through this pathway, IKK-β links extracellular inflammatory stimuli to transcriptional programs that control cytokine production, stress responses, and cellular adaptation[1][3]. In disease contexts, dysregulated IKK-β/NF-κB signaling has been associated with chronic inflammation, cancer, metabolic disorders, cardiovascular disease, and pathogen-driven pathology, making the kinase a widely studied experimental target[1][3]. Compared with the related catalytic isoform IKK-α (CHUK), IKK-β is the predominant kinase mediating canonical NF-κB activation in a NEMO-dependent manner, whereas IKK family members also participate in additional signaling networks beyond classical NF-κB regulation[4]. This functional distinction is important for mechanistic studies aimed at dissecting pathway-specific signaling outputs and inflammatory phenotypes[4]. For experimental applications, pharmacological or genetic inhibition of IKK-β is commonly used to suppress NF-κB activation and evaluate the contribution of inflammatory signaling to disease models, while the expanding spectrum of IKK substrates continues to inform the interpretation of inhibitor-based studies[3][4].

  • Subcellular Localization

    Cytoplasm,Nucleus,Membrane raft

  • Expression


    Tissue_Specificity: Highly expressed in heart, placenta, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis and peripheral blood

  • Isoforms & Post-Translational Modification

    O14920 has four isomers: O14920-1: 86564 Da (predicted); O14920-2: 85945 Da (predicted); O14920-3: 29236 Da (predicted); O14920-4: 79509 Da (predicted).
    Upon cytokine stimulation, phosphorylated on Ser-177 and Ser-181 by MEKK1 and/or MAP3K14/NIK as well as TBK1 and PRKCZ; which enhances activity (PubMed:10022904, PubMed:16207722)丨(Microbial infection) Acetylation of Thr-180 by Yersinia YopJ prevents phosphorylation and activation, thus blocking the I-kappa-B pathway丨Ubiquitinated丨(Microbial infection) Monoubiquitination by TRIM21 is disrupted by Yersinia YopJ丨Hydroxylated by PHD1/EGLN2, loss of hydroxylation under hypoxic conditions results in activation of NF-kappa-B

  • Subunit

    Component of the I-kappa-B-kinase (IKK) core complex consisting of CHUK, IKBKB and IKBKG; probably four alpha/CHUK-beta/IKBKB dimers are associated with four gamma/IKBKG subunits (PubMed:32935379)

  • SwissProt ID

    O14920

  • Synonyms

    IKKB, IKBKB, Inhibitor of nuclear factor kappa-B kinase subunit beta, I-kappa-B-kinase beta, IKK-B, IKK-beta, IkBKB, I-kappa-B kinase 2, Nuclear factor NF-kappa-B inhibitor kinase beta, Serine/threonine protein kinase IKBKB, IKK-2, IKK2, NFKBIKB

References

IKK β Antibody (YA7485) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00